Patent · US Active

Cardiopathy-reducing phosphodiester lipids

US11643424B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 3, 2021
Grant dateMay 9, 2023
Priority date—
Expiry dateMay 3, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes compound having the following structural formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.